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Background. Voiding cystourethrograms are distressing for children and parents. Nonpharmacological methods reduce distress.
Pharmacological interventions for VCUG focus on sedation as well as analgesia, anxiolysis, and amnesia. Sedation has cost, time,
and safety issues. Which agents and route should we use? Are we sure that sedation does not inﬂuence the ability to diagnose
vesicoureteric reﬂux? Methods. Literature search of Medline, EMBASE, and the Cochrane Database. Review of comparative studies
found. Results. Seven comparative studies including two randomised controlled trials were reviewed. Midazolam given orally (0.5-
0.6mg/kg)orintranasally(0.2mg/kg)iseﬀectivewithnoapparenteﬀectonvoidingdynamics.Insuﬃcientevidencetorecommend
other sedating agents was found. Deeper sedating agents may interfere with voiding dynamics. Conclusion. Midazolam reduces
the VCUG distress, causes amnesia, and does not appear to interfere with voiding dynamics. Midazolam combined with simple
analgesia is an eﬀective method to reduce distress to children undergoing VCUG.
Copyright © 2008 David W. Herd. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
The voiding cystourethrogram (VCUG) is the gold standard
for diagnosing vesicoureteric reﬂux (VUR) and a number of
other bladder conditions [1, 2]. The VCUG is a procedure
performed mainly on infants and young children in the
Radiology Department [3]. There is increasing belief that
interventions for VUR are less eﬀective than anticipated, but
much debate remains [4–11]. The child is required to be
conscious, a urinary catheter is inserted, and the bladder
is ﬁlled with radio-opaque material, then the child is asked
to spontaneously void [12]. This procedure creates distress
in the child, the parents, and occasionally staﬀ [13–15].
Nonpharmacological methods to reduce this distress include
education prior to the procedure, distraction during, and
rewards after [14, 16–28].
Pharmacological interventions primarily focus on seda-
tion but also could include beneﬁcial analgesic, anxiolytic,
and amnesic eﬀects [29, 30]. Sedation brings with it cost,
time, and safety concerns [1, 29–33]. It is unknown whether
we can predict which children will go on to have distress
or whether we should sedate routinely [34]. Which agents
should we use, and what is the best route of administration?
The majority of children having VCUG would not have had
one previously. Coping styles and parent-child interaction
are important determinants of distress during a medical
procedure [34]. Safety of sedating agents is excellent in
the context of a sedation service with the necessary staﬀ
and equipment to manage sedation in young children [35–
37]. Those who sedate children should be prepared for
inadvertent deeper sedation, basic life support, and airway
management [29–31, 38–40]. Advanced help should be
available. Time and cost factors limit the introduction of this
distress-reducing intervention. Sedation recovery area and
staﬀtimearebeingtheprimarycostfactors.Themedications
themselves are relatively inexpensive. Finally, are we sure that
sedation does not inﬂuence the VCUGs ability to diagnose
vesicoureteric reﬂux?
2. METHODS
These methods include a sensitive search of PubMed
(1950–2007), EMBASE (1980–2007), Cochrane Database
of Systematic Reviews, and Cochrane Randomised Con-
trolled Trials Register. Articles on VCUG were identiﬁed
through the terms urography (MESH heading exploded),
micturating, or voiding cystourethrogram using wildcard
search for variations of spelling. Acronyms VCUG and
MCUG were also used. To identify sedation articles, the
followingexplodedMESHtermswereused:“hyponoticsand2 Advances in Urology
sedatives,” conscious sedation, midazolam, propofol, chloral
hydrate, and nitrous oxide. “Sedation” was searched for as a
title word. Results of the VCUG search and sedation search
were combined. There were no limits on language for search,
but only English language articles were reviewed. Further
studies were identiﬁed from bibliographies. Unpublished
studies were not actively sought.
3. RESULTS
Medline search (2008) found 234 papers of which 17
were considered to be of interest [6, 8, 13, 14, 16, 41–52].
EMBASE search found 416 papers of which additional 8
papers were of interest [27, 35, 53–59]. Cochrane Ran-
domised Controlled Trials Register found no further articles
of interest. Cochrane Database of Systematic Reviews found
one review on interventions for primary vesicoureteric
reﬂux, but none on sedation for this procedure [7]. A review
of the bibliographies identiﬁed further 39 papers of interest
[2–5, 9, 11, 15, 17–22, 26, 28, 34, 37, 40, 60–81]. Four papers
on anesthesiology for VCUG were found and included for
discussion [82–85].
Any study comparing a sedative against another sedative,
placebo, or standard treatment for VCUG was reviewed. One
French language article [77] and one Polish language article
[56] were not included. Study designs are summarised in
Table 1. Outcome measures and results are in Table 2 [41, 43,
45, 47, 52, 59]. Quality assessment is shown in Table 3.O n l y
two of the studies [45, 52] were of high quality with Jadad
scores[86]of4ormore.Oneunpublishedcomparativestudy
was found, but not included [68].
4. DISCUSSION
The best way to avoid the distress of the VCUG is not
to do the procedure. A better way to image vesicoureteric
reﬂux has recently been discussed in an editorial by Elder
[55]. As much evidence becomes available to show that we
are not inﬂuencing the outcome of VUR, less VCUGs may
be ordered [7, 93]. Possible alternatives include Doppler
ultrasound [94] or ultrasound with contrast [61]. A supra-
pubic approach to avoid catheterisation seems promising
but still requires ﬁlling and voiding [49]. Methods to detect
reﬂux without voiding are impaired as some reﬂux may be
present only on voiding [95], although the fact that whether
t h i si si m p o r t a n to rn o ti sd e b a t e d[ 96]. Nuclear medicine
scanning may be an alternative or may be able to select
those who are more likely to beneﬁt from VCUG [67].
Nuclear medicine cystoscopy replaces radio-opaque contrast
with pharmacolabelled material with lower radiation, but
otherwise it is very similar to the VCUG. Currently, VCUG
remains the gold standard until less invasive tests are
developed [1]. At the very least, we should be perfecting our
current technique [12].
5. DISTRESS, PAIN, AND ANTICIPATORY ANXIETY
Distress is an all encompassing term that may or may not
include a painful stimulus. This can be evidenced by fear
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Figure 1: Bar graph shows the number of children (n = 117) who
experienced serious or severe distress (Groningen distress rating
scale(GDRS)score>2[90])ateachphaseofvoidingcystourethrog-
raphy. 56 received placebo (black bars) and 61 received midazolam
(white bars), from [45].
of a procedure, pain responses prior to nociceptive stimuli,
or anxiety behaviours before a planned event. Distress
during the voiding cystourethrogram has been reported in
observational and controlled studies. Phillips et al. [13]
showed that 52 out of 73 children (71%) experienced serious
distress, severe distress, or panic on the Groningen distress
rating scale [90]. Herd et al. found that serious or severe
distress was detected in 61% of all unsedated children at
some stages during the VCUG. This level of distress may
have been brief but is generally considered unacceptable.
This distress is caused not only by urethral catheterisation,
but also by the distension of the bladder and the subsequent
voiding of urine in a socially abnormal situation (Figure 1).
Nociceptors related to urethral mucosa and stretch receptors
in the bladder provide the peripheral pain signals, but the
majority of the distress is cortical.
Distress can also be manifest in the parent. Parents’
perceptions of fear, distress, and pain in their children are
anticipated to be greater than the reality [51].
6. PSYCHOLOGICAL THERAPY
(NONPHARMACOLOGICAL TREATMENTS)
Psychological treatments should be considered ﬁrst as they
oftenhavelittleornorisk.Therearemanywaystoreducethe
distress of procedures in children [19]a n de v e nm o r ec h a l -
lenges researching and implementing psychological inter-
ventions for controlling children’s pain [97]. Interventions
may range between simple educational [28]a n dm o r e
structured play therapy sessions [14, 76]a n dh y p n o s e s[ 42].
Preparation,distraction,andreassurancebefore,during,and
after the procedure are likely to reduce the distress of the
procedure [22, 69, 75]. Parental presence is comforting for
childrenduringpainfulprocedureandshouldbeencouraged
despite the lack of speciﬁc VCUG evidence [23].David W. Herd 3
Table 1: Studies comparing a sedative against another sedative, placebo, or standard treatment for VCUG. Design and interventions.
(NSD:nosigniﬁcantdiﬀerence;VCUG:voidingcystourethrogram;RNC:radionuclidecystography;VUR:vesicouretericreﬂux;SD:standard
deviation).
Authors; year;
country Title Patients Intervention and
comparison
Nonpharmacological
cointervention
Time of follow-up
and diﬀerences (if
any)
I. Akil, M. Ozkol,O.
Y .I k i z o g l u ,M .P o l a t ,
O. Y. Tuncyurek, O.
Taskin, H. Yuksel;
2005; Turkey [41]
“Premedication
during micturating
cystourethrogram to
achieve sedation and
anxiolysis”
53 (39F;14M), >6m,
median age of 6y
(range from 7m to
11.1y); ﬁrst VCUG
98%
Oral midazolam of
0.6mg/kg (max. of
15mg) versus chloral
hydrate of 25mg/kg
(max. of 500mg)
versus Placebo;
15–30min prior to
VCUG
Parents informed
about MCUG and
permission granted
for sedative drug and
making child nil by
mouth for 3h,
parental presence not
stated
Until they were
allowed to drink
clear liquids, usually
1h after completion
of the procedure
J. S. Elder, R.
Longenecker; 1995;
USA [43]
“Premedication with
oral midazolam for
voiding
cystourethrography
in children: safety
and eﬃcacy”
98 children
previously distressed
by VCUG (38) or
appeared shy
(79F;19M), mean
age of 4.4 (range
from 23m to 9y); 25
controls (21F:4M),
mean age of 4.6
(range not stated);
ﬁrst VCUG 61%
Oral midazolam of
0.6mg/kg (max. of
15mg), 20–30min
prior to VCUG or
NUC versus
standard care
Parents of
intervention
group-contacted
prior with purpose of
midazolam and
expected eﬀects,
parents are allowed to
be present
Phone call at 48h
D. W. Herd, K. A.
McAnulty, N. A.
Keene, D. E.
Sommerville; 2006;
New Zealand [45]
“Conscious sedation
reduces distress in
children undergoing
voiding
cystourethrography
and does not
interfere with the
diagnosis of
vesicoureteric reﬂux:
ar a n d o m i z e d
controlled study”
Children of 1–14y
(eligible); 139
randomised, 117
completed VCUG
on the day
(84F:33M), 8 had
VCUG completed
later, age >1y, mean
ages of 3.6y (SD1.8)
and 3.4y (SD2.1),
ASAI-II
Oral midazolam of
0.5mg/kg (max. of
15mg), 30min prior
to catheter insertion
versus placebo
All oﬀered play
therapy (visit to
department, doll
catheterised),
four-page pamphlet,
only the treatment
group fasted for 6h
with solids and 4h
with liquid (i.e.,
control group was
allowed to eat),
parent/caregiver
present, skilled nurse
did all catheters
60–90min after
medication
I. Keidan, R.
Zaslansky, M.
Weinberg, A.
Ben-Shlush, J. M.
Jacobson, A.
Augarten, Y. Mor;
2005; Israel [47]
“Sedation during
voiding
cystourethrography:
comparison of the
eﬃcacy and safety of
using oral
midazolam and
continuous ﬂow
nitrous oxide”
47 (42F:5M), age of
3–16y, ASAI and II,
mean age of 6 (range
from 3 to 15)
Oral midazolam of
0.5mg/kg (max. of
15mg), 20min prior
to procedure versus
continuous ﬂow
50% nitrous oxide
Both groups fasted
with solids for 6h,
and liquids for 2h,
parents were
encouraged to
accompany the
children throughout
the procedure,
ﬂavoured nasal mask
was used for nitrous
oxide
24h follow-up by
telephone, recovery
time of 63min (SD
25) in midazolam
group, 29min (SD
10) in the N2O
group (p<. 001)
P. A. Merguerian, S.
T. Corbett, J.
Cravero; 2006; USA
[48]
“Voiding ability
using propofol
sedation in children
undergoing voiding
cystourethrograms:
ar e t r o s p e c t i v e
analysis”
544 charts, 287
selected ages from 2
to 8 (preselected),
mean age of 51m
(244F:43M), ﬁrst
VCUG 75%
Sevoﬂurane
induction followed
by propofol infusion
on its own (historical
controls)
Not reported4 Advances in Urology
Table 1: Continued.
Authors; year;
country Title Patients Intervention and
comparison
Nonpharmacological
cointervention
Time of follow-up
and diﬀerences (if
any)
E. Stokland, S.
Andr´ easson, B.
Jacobsson, U. Jodal,
B. Ljung; 2003;
Sweden [52]
“Sedation with
midazolam for
voiding
cystourethrography
in children: a
randomised
double-blind study”
Children of 0.5 to
9y(eligible),95
enrolled
(70F:20M), gender
stratiﬁed, median
age of 2.2y,
midazolam, 3.2
placebo
Intranasal
midazolam of
0.2mg/kg (max. of
5mg),3–5minprior
to bladder catheter
versus placebo
Oral and written
information
Follow-up
questionnaire and
phone call at 48h
J .L .Z i e r ,K .A .
K v a m ,S .C .
Kurachek, M.
Finkelstein; 2007;
USA [59]
“Sedation with
nitrous oxide
compared with no
sedation during
catheterization for
urologic imaging in
children”
Children of 4–18y
selected by
investigator
undergoing VCUG
or RNC, enrolled
204 (165F:39M)
out of 389, mean age
nonsedated: 6.4
(range of 4–15.2),
sedated: 6.3 (range
of 4–14.9)
Continuous ﬂow
70% nitrous oxide
until catheterisation
is complete versus
standard care
All patients fasted for
4h
To time of discharge,
longer in sedated
group, 85min versus
33min (P<0.001)
Those who have been previously distressed by VCUG
would seem to be ideal candidates for sedation, but the
majority of children would not have had a previous VCUG.
Factors which may reduce distress in children during
VCUG include “eﬀortful control” by the child and coping
and distress-promoting behaviours by the parent [34]. No
validated prediction tool exists for VCUG distress.
7. PHARMACOTHERAPY
Pharmacotherapy includes sedation, anxiolysis, analgesia,
amnesia, and anesthesia.
7.1. Sedatingagents
Sedation continues to be diﬃcult to deﬁne[63]. In the case
of the VCUG, a degree of consciousness is required. This
may be deﬁned as light sedation, and the use of oxymoron
“conscious sedation” is being discouraged [98].
Midazolam
Of the selected studies, 5 had midazolam as a treatment arm
and4ofwhichwereoralandoneintranasal.Oralmidazolam
dose was 0.5mg/kg in two studies [45, 47] and 0.6mg/kg in
two other studies [41, 43]. Maximum dose was 15mg in all.
Time between ingestion and procedure ranged from 15 to 30
minutes. Intranasal dose in one study was 0.2mg/kg with a
maximum of 5mg, and it was administered 5 minutes before
the procedure [52]. A number of behavioural measures were
employed (Table 1). All the studies demonstrate signiﬁcantly
less distress with midazolam in a variety of measurement
tools. Few adverse eﬀects were encountered. Midazolam
may cause adverse paradoxical agitated reactions in less
than 5% of children [99]. These reactions have been shown
in case reports to be ameliorated using the antidote for
midazolam (ﬂumazenil) both in adults [100] and children
[101]. Ketamine, a dissociative anesthetic, has been shown
to be more eﬀective than increased doses of midazolam or
placebo in a randomised controlled trial [99].
The study by Stockland et al. [52] on 95 children com-
pared intranasal midazolam (0.2mg/kg with a maximum of
5mg)toplacebo.Nursesreportedatrendtoeasierprocedure
in the midazolam group (P = .07), with girls reported easier
thanboys(P = .06).Noseriousadverseeventswerereported.
Parents felt that the administration of midazolam was more
uncomfortable than that of placebo (P<. 001). Parents
felt that midazolam made catheterisation, voiding, and the
overall procedure more comfortable (P = .015, P = .08, and
P = .047,resp.).TheauthorsreportP-valuesandnoabsolute
scores,whichmakesitimpossibletoestimatetreatmenteﬀect
size or clinical relevance.
A study by the current author and colleagues [45]
compared oral midazolam (0.5mg/kg with a maximum
of 15mg) to placebo in 125 children who had VCUG.
Behavioural observations were completed in 117. This was
the only study that calculated a priori power requirement
or attempted to quantify the treatment eﬀect. We rated
our paper highly using the Jadad score [86]. We found no
serious adverse events. The number of children experiencing
serious or severe distress (Groningen distress rating scale
(GRDS) >2) at any stage of the procedure was 34 (61%) in
the placebo group and 16 (26%) in the midazolam group.
Number needed to treat to reduce serious or severe distress
in one child was 2.9 (95%CI 1.9–5.5). VUR was identiﬁed in
16% of all children. This study was limited to children above
the age of one year.David W. Herd 5
Table 2:Studiescomparing asedative against anothersedative, placebo, orstandardtreatmentforVCUG.Outcomes,results,andfollow-up.
(NSD:nosigniﬁcantdiﬀerence;VCUG:voidingcystourethrogram;RNC:radionuclidecystography;VUR:vesicouretericreﬂux;SD:standard
deviation).
Authors; year;
country
Sedation score
outcome and results
Distress outcome(s)
and results
Urological
outcome(s) and
results
Safety outcome(s)
and adverse events
I. Akil, M. Ozkol, O.
Y. Ikizoglu, M. Polat,
O. Y. Tuncyurek, O.
Taskin, H. Yuksel;
2005; Turkey [41]
Breitkopf and Buttner
classiﬁcation of
emotional status [87],
1.87 (SD0.72) in
midazolam versus
1.35 (SD0.49) in
control (P = .01),
duration of sedation
is 68min
(midazolam), 28min
(chloral), P<. 001
Frankl behaviour
rating score [88]
NSD; Spielberger’s
state anxiety
inventory [41] NSD;
Houpt behaviour
scale [88]o f4 . 9 3
(SD1.12) in
midazolam group
versus control of 4.12
(SD 1.05) in chloral
group, all NSD
Postvoid residual
volume, VCUG
grading, no diﬀerence
found
None found, deﬁned
as drop in PaO2/Sats
by 5%, systolic blood
pressure drop of
15mm Hg, drop in
pulse to 60bpm
J. S. Elder, R.
Longenecker; 1995;
USA [43]
None
Phone call at 48h,
recall, behavioural
side eﬀects; parental
wishes, 97 out of 98
contacted, 56 children
(60%), no recall of
VCUG, 19 (21%)
recalled parts, 10
remembered the
procedure without
negative experience, 9
recalled a negative
experience, 12 out of
97 children had
behavioural side
eﬀects reported after
the study, 92 out of 97
(95%) parents of
sedated children
would request the use
of midazolam again
Postvoid residual
volume (Bis and
Slovis method [89]),
no residual volume in
74% of midazolam
group and 72% of
control group; NSD
Saturation decrease
by 10%, systolic BP
drop by 15mm Hg,
respective rate down
to 8/min, HR down to
60/min, one child had
a transient decrease in
saturation requiring
no intervention
D. W. Herd, K. A.
McAnulty, N. A.
Keene, D. E.
Sommerville; 2006;
New Zealand [45]
None
Independent observer
Groningen distress
rating scale [90];
nursing GDRS; heart
rate; parent-child
interaction, 61% of
placebo group
experienced serious
or severe distress
(GDRS of 3 or 4);
26% of midazolam
group had the same
distress; number
needed for treatment
was 2.9 (95%CI
1.9–5.5)
VUR grade; volume
infused, no diﬀerence
in volume infused
(P = .8), no
diﬀerence in VUR
grading (P = .31), a
priori power of 90%
Oxygen requirement
(Sats <94%), two
children in
midazolam group had
transient
desaturations to less
than 94% and were
given oxygen
Nitrousoxide(N2O)
Two studies evaluated nitrous oxide given with continuous
ﬂow devices at 50% and 70%. Keidan et al. compared 50%
nitrous oxide in 23 children to 0.5mg/kg oral midazolam
in 24 children without a placebo group [47]. They found
no diﬀerence between midazolam and 50% nitrous oxide
although they did not design this as an equivalence study,
and no power calculation was done. There was a trend for
the time to micturition to be longer in the nitrous group6 Advances in Urology
Table 2: Continued.
Authors; year;
country
Sedation score
outcome and results
Distress outcome(s)
and results
Urological
outcome(s) and
results
Safety outcome(s)
and adverse events
I. Keidan, R.
Zaslansky, M.
Weinberg, A.
Ben-Shlush, J. M.
Jacobson, A.
Augarten, Y. Mor;
2005; Israel [47]
AVPU (alert,
responds to voice,
responds to pain,
unresponsive)
FLACC (face, legs,
activity, crying,
consolability) score
for pain [91]; anxiety
score (observer scale
of behavioural
distress) [92]; no
diﬀerence between
midazolam and
nitrous oxide,
number of children
requiring physical
restraint is 10/24 in
midazolam and 2/23
for N2O (P = .01)
Time to micturition
7.2 (SD2.5) min for
midazolam and 15.3
(SD 17.3), P = .8
Oxygen saturation
<93%, alteration in
heart rate or BP by
15% from baseline,
oversedation deﬁned
as “U” on the AVPU
scale
P. A. Merguerian, S. T.
Corbett, J. Cravero;
2006; USA [48]
Not reported None
Void to completion;
sedated children
(55%) could void to
completion compared
to 89% nonsedated
(P<. 001)
Not reported
E. Stokland, S.
Andr´ easson, B.
Jacobsson, U. Jodal, B.
Ljung; 2003; Sweden
[52]
None
VAS from 0 mm to
100mm (severe
problems); nurse
observation VAS
NSD, parent VAS,
administration of
midazolam more
uncomfortable
(P<. 001), catheter,
and overall procedure
more uncomfortable
with placebo
(P<. 001); parent
follow-up
questionnaire at 12,
24, and 48 h of
“reactions,” NSD
VUR grade; volume
infused; ability to
void; NSD
Not deﬁned, none
reported
J .L .Z i e r ,K .A .K v a m ,
S. C. Kurachek, M.
Finkelstein; 2007;
USA [59]
None
Brief behavioural
distress score (BBDS)
for VCUG, median
age of 44 (range of
11–100) nonsedated,
11 (range of 0–67)
sedated (P<. 001),
patient self-reported
Wong-Baker FACES
pain rating scale, 6
after catheter in
nonsedated, 0 in
sedated (P<. 001)
Time to bladder
emptying; NSD
One patient in
sedated group
experienced nausea,
no desaturations
(15.3 minutes versus 7.2 minutes), but it did not reach sta-
tistical signiﬁcance (P = .08). Nitrous oxide was signiﬁcantly
faster with regard to recovery time, with recovery in 29
minutes versus 63 minutes (P<. 001). Zier et al. used 70%
continuous nitrous oxide only for urethral catheterisation
phase of VCUG in an older group of 107 children, and
compared this to standard treatment in other 107 children
[59]. The authors chose not to randomise the study based
on diﬃculties with recruitment and parental expectations.
Briefbehaviouraldistressscores(BBDSs)weredemonstratedDavid W. Herd 7
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by the observational tool selected[102]. Wong-Baker FACES
scale was the self-report tool used [103]. For the VCUG
group (n = 101), BBDS was 44 (range of 11–100) in the
nonsedated group versus 11 (range of 0–67) for the sedated
group (P<. 001). Immediately after catheterisation, the
Wong-Baker FACES scale median was 6 for the nonsedated
group and 0 for the sedated group (P<. 001). Both studies
reported time of completion, but neither study reported
VUR grading or residual volume.
Otheragents
Choral hydrate was compared to oral midazolam and
placebo in one study [41]. A dose of 25mg/kg was not found
to be statistically diﬀerent from placebo in reducing distress.
This may have been due to inadequate dose or lack of power
in the study. The sedation scale was also not signiﬁcant for
chloral versus placebo and, therefore, it suggests too low a
dose was selected. There is no enough data to make any
assessment of eﬀect on voiding dynamics.
One retrospective study of propofol using historical
controls was selected for review [48]. While this was an
attempt to create a sedative state using low-dose propofol,
the study required the presence of an anesthetist. During
this study, low-dose propofol infusion followed sevoﬂurane
gas induction and intravenous cannula insertion. This study
found that propofol reduced the ability of children to
completely void, which may interfere with the diagnosis of
VUR.
7.2. Anxiolysis
Midazolam in the doses used in the reviewed studies is
anxiolytic. Many children may appear fully conscious yet
more cooperative, while another child given the same dose
may appear sleepy. Where anxiolysis ends and sedation
begins is unclear, but there would be a large overlap.
7.3. Analgesia
There is a wide range of analgesics available for children
[104]. Midazolam does not provide any analgesia and,
therefore, should be supplemented with a simple analgesic.
Acetaminophen
Acetaminophen is the most commonly provided childhood
analgesic with low side eﬀects and cost. It is routinely oﬀered
priortootherpotentiallypainfulproceduresinchildrensuch
as vaccination. Acetaminophen is usually provided in a sweet
syrup base, and could be used to disguise the bitter taste of
midazolam. There are many formulations of acetaminophen
syrup, and palatability may vary [105].
Oralsucrose
Oral sucrose is an eﬀective analgesic in new-born babies, and
has been subject to several controlled trials and a Cochrane
review [106]. While no studies have examined its eﬀect for
VCUG distress, it seems a simple likely eﬀective intervention
with low risk for children under 3 months of age.
Nitrousoxide
Nitrous oxide is a strong analgesic antagonising central
NMDA receptors, and this is a potential advantage over
midazolam. Study of Keidan et al. comparing midazolam
to continuous ﬂow nitrous oxide found no diﬀerence in
FLACC scores [91], a measure of pain used more recently
for procedural distress [107]. Study of Keidan et al. was not
designed as an equivalence study, and no power calculations
were done; so a true diﬀerence may not have been detected
by the study.
Opiates
No studies have looked at opiate use for VCUG distress.
Intranasal midazolam has proven eﬀective, and opiates may
also be administered by this route. Intranasal fentanyl shows
promise as a rapid, easy-to-administer analgesic for severe
pain in the children’s Emergency Department [108]. Opiates
may interfere with bladder function [109].
Localanesthetics
Lignocaine gel has been shown to reduce the pain of
catheterisation for VCUG, but a 10-minute process of
repeated application of lignocaine gel to the urethral meatus
is required. The authors did not measure the eﬀect of this
procedure but only the reduced pain of catheterisation that
followed. It would seem reasonable to use it with low risk
of harm but at added cost [66]. Further study on children is
required.
7.4. Anesthesia
There is increasing use of deeper sedation outside the oper-
ating room by nonanesthesiologists [110]. There is debate
about which agents should be used outside the operating
room and who should provide this service [63]. For VCUG,
anesthetics have been given to avoid the trauma associated
with urethral catheterisation, and then the child is allowed
to wake and complete the VCUG. This does not avoid the
distress caused by bladder distension or micturition. It also
requires an anesthetist and the full costs associated with
anesthesia and recovery.
8. WHO SHOULD RECEIVE SEDATION?
Many children do not experience distress during the VCUG.
This may be related to previous experience, coping style,
parental inﬂuence, staﬀ skill, and empathy. Developmental
considerationsandeducationlevelofthechildandparentare
important.Nevertheless,manychildren,whowouldnothave
been predicted, may go on to experience distress. Parental
perceptions of the procedure are such that most parents
would request some medication if it were eﬀective, safe, and
available [43, 47].David W. Herd 9
9. DOES SEDATION AFFECT THE ABILITY OF
THE VCU TO DIAGNOSE REFLUX?
Eﬀect of sedation on ability to void can be measured
with indirect or direct measures. Indirect measures include
ﬁlling volume, residual volume, and time of micturition.
Bozkurt et al. carefully examined urodynamic variables
under the inﬂuence of midazolam [62]. They used a high-
intranasal dose of 0.5mg/kg. Stockland et al. used intranasal
midazolam at a dose of 0.2mg/kg, and found no diﬀerence
in reﬂux grading between the groups [52]. They did not
perform a power calculation, so there is still the possibility
of missing a true eﬀect. Herd et al. considered a clinically
important diﬀerence in VUR to be a true shift of one grade
down by half of the subjects with the use of midazolam [45].
It was important to detect a diﬀerence, so a 90% power was
used. There was no diﬀerence in VUR grading between the
groups (nonlinear mixed model analysis, P = .31). There
was no evidence of a diﬀerence in volume infused between
the two groups (P = .08).
10. CONCLUSIONS
Sedation reduces distress of the micturating cystourethro-
gram in children previously distressed or likely to be
distressed. Midazolam is the agent most studied, and has
an excellent safety proﬁle. An oral dose of 0.5-0.6mg/kg or
intranasal dose of 0.2mg/kg seems eﬀective. Most children
have not had a VCUG previously, and it may be diﬃcult
to predict which of them will go on to have distress. When
giving oral midazolam of 0.5mg/kg to children routinely,
the number needed to treat them is 2.9 (95%CI 1.9–5.5)
to eliminate serious or severe distress. Continuous ﬂow
nitrous oxide appears promising, particularly with a fast
onset and recovery time, but it has greater potential for
deepersedation.Thismayinterferewithvoiding,andfurther
studies are required. Midazolam appears not to interfere
with the VCUG’s ability to diagnose vesicoureteric reﬂux
using indirect (residual volume) and direct (VUR grading)
measures. There are many children who would avoid distress
if they were given sedation. Local sedation services should be
engaged, and safety guidelines should be followed to ensure
that this eﬀective treatment might be implemented safely.
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